New drugs to face affordability test

Proposed changes to the UK’s drug approval process should be the subject of an honest debate according the country’s Multiple Sclerosis Society. The changes will mean the National Health Service (NHS) in England will assess how much it can afford to pay for new drugs. Under the plan, new drugs that are expected to cost … Continue reading New drugs to face affordability test

Advertisement